Etzer Darout
Stock Analyst at Barclays
(4.97)
# 84
Out of 4,668 analysts
517
Total ratings
64.9%
Success rate
34.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Etzer Darout
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TVRD Tvardi Therapeutics | Maintained: Sell | $3 | $1.84 | +63.49% | 10 | Aug 20, 2026 | |
| ELVN Enliven Therapeutics | Initiated Coverage: Buy | $78 | $58.92 | +32.38% | 1 | Aug 18, 2026 | |
| MGNX MacroGenics | Maintained: Buy | $6 | $4.07 | +47.42% | 34 | Aug 14, 2026 | |
| SMMT Summit Therapeutics | Maintained: Hold | $18 | $12.43 | +44.81% | 12 | Aug 13, 2026 | |
| MNPR Monopar Therapeutics | Maintained: Buy | $125 → $128 | $110.88 | +15.44% | 9 | Aug 13, 2026 | |
| KURA Kura Oncology | Maintained: Buy | $28 | $11.71 | +139.11% | 14 | Aug 12, 2026 | |
| FBRX Forte Biosciences | Reiterated: Hold | $77 | $76.89 | +0.14% | 3 | Aug 12, 2026 | |
| CCCC C4 Therapeutics | Maintained: Buy | $7 | $4.03 | +73.70% | 30 | Aug 12, 2026 | |
| TRAX First Tracks Biotherapeutics | Maintained: Buy | $48 → $65 | $41.90 | +55.13% | 5 | Aug 12, 2026 | |
| ORKA Oruka Therapeutics | Maintained: Buy | $160 | $104.86 | +52.58% | 8 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 → $78 | $21.26 | +266.89% | 11 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $48 → $53 | $39.94 | +32.70% | 8 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 → $13 | $8.99 | +44.61% | 12 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $3.29 | +386.32% | 31 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $14.33 | +95.39% | 7 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 | $55.25 | -0.45% | 20 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 → $30 | $19.70 | +52.28% | 7 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $14 | $17.28 | -18.98% | 7 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $49 | $53.69 | -8.74% | 34 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 | $27.00 | - | 32 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $403 → $407 | $369.16 | +10.25% | 9 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $151 → $153 | $150.69 | +1.53% | 11 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $9.21 | +225.73% | 11 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 | $19.75 | +87.34% | 15 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $9.03 | +121.61% | 36 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $260 → $270 | $248.70 | +8.56% | 7 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $75 | $56.59 | +32.52% | 12 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $134 → $139 | $127.22 | +9.26% | 17 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $148 | $118.20 | +25.22% | 11 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 → $119 | $121.50 | -2.06% | 5 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $4.66 | n/a | 1 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $130 → $143 | $110.89 | n/a | 10 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $156.24 | n/a | 7 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.45 | n/a | 16 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $15.86 | n/a | 4 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $33.41 | n/a | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $27.05 | n/a | 2 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.01 | n/a | 7 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.20 | n/a | 10 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $63 | $0.6912 | n/a | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | kr 2,445 → kr 2,612 | kr 2,141 | n/a | 2 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 → $37 | $97.07 | n/a | 2 | Sep 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $60 | $0.523 | n/a | 1 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 | $0.00001 | n/a | 1 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $25 | $6.52 | n/a | 2 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $48 | $3.90 | n/a | 2 | Mar 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €22.26 → €25.69 | €3.96 | n/a | 2 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $162 | $229.30 | n/a | 1 | Feb 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $48 | $26.57 | n/a | 4 | Jul 14, 2020 |
Tvardi Therapeutics
Aug 20, 2026
Maintained: Sell
Price Target: $3
Current: $1.84
Upside: +63.49%
Enliven Therapeutics
Aug 18, 2026
Initiated Coverage: Buy
Price Target: $78
Current: $58.92
Upside: +32.38%
MacroGenics
Aug 14, 2026
Maintained: Buy
Price Target: $6
Current: $4.07
Upside: +47.42%
Summit Therapeutics
Aug 13, 2026
Maintained: Hold
Price Target: $18
Current: $12.43
Upside: +44.81%
Monopar Therapeutics
Aug 13, 2026
Maintained: Buy
Price Target: $125 → $128
Current: $110.88
Upside: +15.44%
Kura Oncology
Aug 12, 2026
Maintained: Buy
Price Target: $28
Current: $11.71
Upside: +139.11%
Forte Biosciences
Aug 12, 2026
Reiterated: Hold
Price Target: $77
Current: $76.89
Upside: +0.14%
C4 Therapeutics
Aug 12, 2026
Maintained: Buy
Price Target: $7
Current: $4.03
Upside: +73.70%
First Tracks Biotherapeutics
Aug 12, 2026
Maintained: Buy
Price Target: $48 → $65
Current: $41.90
Upside: +55.13%
Oruka Therapeutics
Aug 11, 2026
Maintained: Buy
Price Target: $160
Current: $104.86
Upside: +52.58%
Aug 11, 2026
Maintained: Buy
Price Target: $80 → $78
Current: $21.26
Upside: +266.89%
Aug 7, 2026
Maintained: Buy
Price Target: $48 → $53
Current: $39.94
Upside: +32.70%
Aug 7, 2026
Maintained: Buy
Price Target: $11 → $13
Current: $8.99
Upside: +44.61%
Aug 7, 2026
Maintained: Buy
Price Target: $16
Current: $3.29
Upside: +386.32%
Aug 7, 2026
Maintained: Buy
Price Target: $28
Current: $14.33
Upside: +95.39%
Aug 7, 2026
Maintained: Buy
Price Target: $55
Current: $55.25
Upside: -0.45%
Aug 7, 2026
Maintained: Buy
Price Target: $27 → $30
Current: $19.70
Upside: +52.28%
Aug 7, 2026
Maintained: Sell
Price Target: $14
Current: $17.28
Upside: -18.98%
Aug 6, 2026
Maintained: Hold
Price Target: $49
Current: $53.69
Upside: -8.74%
Aug 6, 2026
Maintained: Buy
Price Target: $27
Current: $27.00
Upside: -
Aug 6, 2026
Maintained: Buy
Price Target: $403 → $407
Current: $369.16
Upside: +10.25%
Aug 6, 2026
Maintained: Buy
Price Target: $151 → $153
Current: $150.69
Upside: +1.53%
Aug 6, 2026
Maintained: Buy
Price Target: $30
Current: $9.21
Upside: +225.73%
Aug 5, 2026
Maintained: Buy
Price Target: $37
Current: $19.75
Upside: +87.34%
Aug 5, 2026
Maintained: Buy
Price Target: $20
Current: $9.03
Upside: +121.61%
Aug 4, 2026
Maintained: Buy
Price Target: $260 → $270
Current: $248.70
Upside: +8.56%
Jul 31, 2026
Maintained: Buy
Price Target: $75
Current: $56.59
Upside: +32.52%
Jul 28, 2026
Reiterated: Buy
Price Target: $134 → $139
Current: $127.22
Upside: +9.26%
Jun 30, 2026
Maintained: Buy
Price Target: $148
Current: $118.20
Upside: +25.22%
Dec 8, 2025
Maintained: Buy
Price Target: $70 → $119
Current: $121.50
Upside: -2.06%
Apr 4, 2025
Maintained: Buy
Price Target: $9
Current: $4.66
Upside: n/a
Mar 11, 2025
Maintained: Buy
Price Target: $130 → $143
Current: $110.89
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $156.24
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $2.45
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $15.86
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $33.41
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $27.05
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $7.01
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $2.20
Upside: n/a
Feb 27, 2025
Initiated Coverage: Buy
Price Target: $63
Current: $0.6912
Upside: n/a
Aug 11, 2022
Maintained: Hold
Price Target: kr 2,445 → kr 2,612
Current: kr 2,141
Upside: n/a
Sep 13, 2021
Maintained: Buy
Price Target: $38 → $37
Current: $97.07
Upside: n/a
May 18, 2021
Initiated Coverage: Buy
Price Target: $60
Current: $0.523
Upside: n/a
May 18, 2021
Initiated Coverage: Buy
Price Target: $7
Current: $0.00001
Upside: n/a
Mar 17, 2021
Maintained: Buy
Price Target: $16 → $25
Current: $6.52
Upside: n/a
Mar 11, 2021
Reiterated: Buy
Price Target: $50 → $48
Current: $3.90
Upside: n/a
Mar 5, 2021
Maintained: Buy
Price Target: €22.26 → €25.69
Current: €3.96
Upside: n/a
Feb 22, 2021
Downgraded: Hold
Price Target: $162
Current: $229.30
Upside: n/a
Jul 14, 2020
Maintained: Buy
Price Target: $48
Current: $26.57
Upside: n/a